Day's Low
52 Week's Low
Returns % | |
1 Month Return | + 41.4 % |
3 Month Return | + 118.09 % |
1 Year Return | + 62.32 % |
Market Stats | |
Previous Close | ₹70.90 |
Open | ₹70.90 |
Volume | 6,138.00 |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹72.98Cr |
P/E Ratio | -393.89 |
PEG Ratio | 2188.27 |
Market Cap | ₹72.98 Cr |
P/B Ratio | 6.11 |
EPS | 0 |
Dividend Yield | 0 |
Sector | Healthcare |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹72.98 Cr | 17.02% | 0.58 | NA | NA | |
BUY | ₹10,004.72 Cr | 8.37% | 0.50 | ₹176 Cr | ₹1,069 Cr | |
NA | ₹57.40 Cr | -10.45% | 0.55 | NA | NA | |
NA | ₹60.72 Cr | -13.2% | 0.51 | ₹1 Cr | ₹59 Cr | |
NA | ₹230.21 Cr | 23.99% | 0.00 | ₹3 Cr | ₹47 Cr |
Organisation | Aspira Pathlab & Diagnostics Ltd |
Headquarters | Mumbai |
Industry | Healthcare |
E-voting on shares | Click here to vote |
Key events for Aspira Pathlab & Diagnostics Ltd
Aspira Pathlab & Diagnostics reported a 12.04% YoY increase in net sales for March 2024, with quarterly net loss at Rs. 0.50 crore down 93.84% from the previous year. The stock has given -29.40% returns over the last 6 months and -3.87% over the last 12 months.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Retail Holding Up
Retail Investor have increased holdings from 81.28% to 81.45% in Sep 2024 quarter
Price Rise
In the last 7 days, Aspira Pathlab stock has moved up by 10.3%
Against Peers
In the last 1 year, Fortis Healthcare Ltd has given 78.1% return, outperforming this stock by 15.7%
Against Peers
In the last 3 years, Max Healthcare Institute Ltd has given 164.1% return, outperforming this stock by 180.5%
Promoter Holding Down
Promoters have decreased holdings from 18.72% to 18.55% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 18.55% | ||
Foreign Institutions | 0% | 0.00 | |
Mutual Funds | 0% | 0.00 | |
Retail Investors | 81.45% | 0.22 | |
Others | 0% | 0.00 |
Aspira Pathlab & Diagnostics Ltd in the last 5 years
Lowest (-393.89x)
November 26, 2024
Today (-393.89x)
November 26, 2024
Industry (99.92x)
November 26, 2024
Highest (0.00x)
September 27, 2024
Aspira Pathlab & Diagnostics Ltd’s net profit jumped 106.94% since last year same period to ₹0.05Cr in the Q1 2024-2025. On a quarterly growth basis, Aspira Pathlab & Diagnostics Ltd has generated 110% jump in its net profits since last 3-months.
Read More about Earnings ResultsBearish
Neutral
Bullish
Aspira Pathlab & Diagnostics Ltd is currently in a Bullish trading position according to technical analysis indicators.
Aspira Pathlab & Diagnostics Ltd (540788) share price today is ₹74.44
Aspira Pathlab & Diagnostics Ltd is not listed on NSE
Aspira Pathlab & Diagnostics Ltd is listed on BSE
PE Ratio of Aspira Pathlab & Diagnostics Ltd is -393.89
PE ratio = Aspira Pathlab & Diagnostics Ltd Market price per share / Aspira Pathlab & Diagnostics Ltd Earnings per share
Today’s traded volume of Aspira Pathlab & Diagnostics Ltd(540788) is 6,138.00.
Today’s market capitalisation of Aspira Pathlab & Diagnostics Ltd(540788) is ₹72.98Cr.
Aspira Pathlab & Diagnostics Ltd(540788 | Price |
---|---|
52 Week High | ₹74.44 |
52 Week Low | ₹25 |
Aspira Pathlab & Diagnostics Ltd(540788) share price is ₹74.44. It is down -0.00% from its 52 Week High price of ₹74.44
Aspira Pathlab & Diagnostics Ltd(540788) share price is ₹74.44. It is up 197.76% from its 52 Week Low price of ₹25
Aspira Pathlab & Diagnostics Ltd(540788 | Returns |
---|---|
1 Day Returns | 3.54% |
1 Month Returns | 41.4% |
3 Month Returns | 118.09% |
1 Year Returns | 62.32% |